1. Retrospective review of Her2 positive metastatic breast cancer patients who received Pertuzumab and Herceptin as a first line therapy at KFSH&RC (single institute experience) from 2013 to 2016. (March 2019) Authors: Suleman, K.; Mushtaq, A.; Haque, E.; Badran, A.; Ajarim, D.; Tweigeri, T.; Elashwah, A.; Shahin, A.; Khan, K.; Alsayed, A. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗